Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 May-Jun;37(3):963-971.
doi: 10.21873/invivo.13170.

Stereotactic Arrhythmia Radioablation (STAR): A Multidisciplinary Narrative Minireview of Preclinical Studies

Affiliations
Review

Stereotactic Arrhythmia Radioablation (STAR): A Multidisciplinary Narrative Minireview of Preclinical Studies

Erika Galietta et al. In Vivo. 2023 May-Jun.

Abstract

The aim of this narrative review of the literature was to collect and analyze the results of the published preclinical studies on stereotactic arrhythmia radioablation (STAR) in the treatment of refractory cardiac arrhythmias. A literature search was conducted on PubMed using the following terms: ("stereotactic" OR "SBRT" OR "SABR" OR "radioablation" OR "radiosurgery") AND ("arrhythmia" OR "tachycardia"). Preclinical and pathological reports published in English without time limit, comprising studies of STAR in animal models and histological analyzes of explanted animal and human hearts were included. The analyzed studies confirm that doses lower than 25 Gy seem to produce sub-optimal therapeutic results whereas doses >35 Gy are less safe in terms of radiation-induced toxicity. However, long-term results (>1 year) are still missing and reporting outcomes based on low dose irradiation (≤15 Gy). Finally, STAR proved to be an effective therapy in the analyzed studies despite the irradiation of rather different cardiac targets. Therefore, additional studies are needed to: 1) compare the outcomes of STAR at doses of 25 Gy versus 30 Gy; 2) evaluate the long-term results (>1 year) in animal models irradiated at doses similar to those used in the clinic; 3) define the optimal target.

Keywords: Arrhythmia; literature review; narrative review; preclinical studies; radioablation; review; stereotactic radiotherapy.

PubMed Disclaimer

Conflict of interest statement

The Authors declare no conflicts of interest in relation to this study.

Figures

Figure 1
Figure 1. Main effects of stereotactic arrhythmia radioablation (STAR).

References

    1. van der Ree MH, Blanck O, Limpens J, Lee CH, Balgobind BV, Dieleman EMT, Wilde AAM, Zei PC, de Groot JR, Slotman BJ, Cuculich PS, Robinson CG, Postema PG. Cardiac radioablation-A systematic review. Heart Rhythm. 2020;17(8):1381–1392. doi: 10.1016/j.hrthm.2020.03.013. - DOI - PubMed
    1. Lydiard PGDip S, Blanck O, Hugo G, O’Brien R, Keall P. A review of cardiac radioablation (CR) for arrhythmias: Procedures, technology, and future opportunities. Int J Radiat Oncol Biol Phys. 2021;109(3):783–800. doi: 10.1016/j.ijrobp.2020.10.036. - DOI - PubMed
    1. Fahimian B, Loo B, Soltys S, Zei P, Lo A, Maguire P, Gardner E, Wang L. First in-human stereotactic arrhythmia radioablation (STAR) of ventricular tachycardia: Dynamic tracking delivery analysis and implications. Int J Radiat Oncol Biol Phys. 2015;93(3):E466–E467. doi: 10.1016/J.IJROBP.2015.07.1738. - DOI
    1. Cvek J, Neuwirth R, Knybel L, Molenda L, Otahal B, Pindor J, Murárová M, Kodaj M, Fiala M, Branny M, Feltl D. Cardiac radiosurgery for malignant ventricular tachycardia. Cureus. 2014;6(7):e190. doi: 10.7759/cureus.190. - DOI
    1. Cuculich PS, Schill MR, Kashani R, Mutic S, Lang A, Cooper D, Faddis M, Gleva M, Noheria A, Smith TW, Hallahan D, Rudy Y, Robinson CG. Noninvasive cardiac radiation for ablation of ventricular tachycardia. N Engl J Med. 2017;377(24):2325–2336. doi: 10.1056/NEJMoa1613773. - DOI - PMC - PubMed